OrthoPediatrics Corp（KIDS）のニュースとイベントKIDSOrthoPediatrics Corp

OrthoPediatrics Receives FDA Clearance for Pediatric Nailing System

OrthoPediatrics announced U.S. Food and Drug Administration clearance of the Pediatric Nailing Platform Femur Retrograde Nail System and the successful completion of the first procedures using the system. The system was designed specifically for pediatric anatomy and includes anatomic nails for trauma and straight nails for deformity. The system will be available through a limited market release for the remainder of the year, with broader commercialization planned for 2027. "Our Pediatric Nailing Platform has supported nearly 15,000 patients worldwide, demonstrating the impact of our differentiated approach to pediatric orthopedic care. The FDA clearance of PNP Retrograde expands our portfolio and creates an opportunity to reach more children with implants designed specifically for their needs. With the first surgical case already complete, we are encouraged by the initial adoption of this latest addition to our platform. By addressing the unique anatomical needs of growing children that adult-focused systems may not fully accommodate, we continue to strengthen OrthoPediatrics' position as a leader in pediatric-specific orthopedic solutions," said Joe Hauser.

OrthoPediatrics Q3 Revenue $72.66M, Beats Expectations

Reports Q3 revenue $72.66M, consensus $68.5M. "In the third quarter, we continued to build on the momentum in our business, gaining share in Trauma and Deformity and Scoliosis globally, and continued substantial progress with our OPSB strategy. This quarter, we not only drove revenue growth, but we continued to improve profitability, and generated positive free cash flow. We remain confident in our ability to continue to drive these metrics forward," said David Bailey, President & CEO of OrthoPediatrics. "Our innovation super cycle is an important part of that opportunity, with a strong pipeline of new products coming over the next several years that are expected to deliver higher value and improved capital efficiency. We believe these launches will be an important driver of our financial performance as we bring new solutions to more surgeons and hospitals. There are still significant unmet needs in pediatric orthopedics, and we believe OrthoPediatrics is well positioned to capitalize on that opportunity. Our focus remains on growing the business, improving our operating performance, and achieving breakeven or better free cash flow on an annual basis in 2026 and beyond while continuing to deliver innovative solutions for children."

OrthoPediatrics Launches Traxio Complete Weight System

OrthoPediatrics announced the launch of the Traxio Complete Weight System, in collaboration with Synetik Group, Inc. "The introduction of TRAXIO reflects our ongoing commitment to advancing pediatric scoliosis through thoughtful innovation," said Joe Hauser, OrthoPediatrics specialty bracing division president. "TRAXIO offers a reliable, adaptable traction system that supports patient safety while reinforcing our focus on important solutions often overlooked by others, and meaningfully extends the continuum of care from bracing through surgery when needed."